
Our CritCare Division, with dedicated teams in the UK and Ireland, has earned a reputation of supporting and introducing unique landmark technologies that always seek to improve patient outcomes by reducing infection rates, risk, costs and procedural time to allow increased efficiency. For example in IV access our Clave needlefree connectors reduce bacterial colonization and have a clinically proven protection against a wide array of gram-positive bacteria including S.Epidermidis, MRSA, and S.Aureus, 'gram-negative bacteria.